Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

  • Jeanett Fischgräbe, Martin Götte, Katharina Michels, Ludwig Kiesel, Pia Wülfing
  • International Journal of Cancer, February 2010, Wiley
  • DOI: 10.1002/ijc.25076

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/ijc.25076

The following have contributed to this page: Professor Martin Götte